{
    "2019-02-01": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance",
                "features": {
                    "keywords": [
                        "Roche",
                        "Sales",
                        "Up",
                        "Solid",
                        "New Drugs",
                        "Performance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "XLV",
                        "AMGN",
                        "ABBV",
                        "LLY"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Q4 Earnings",
                        "Pipeline Updates",
                        "PFE",
                        "RHHBY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Union Pacific",
                        "AbbVie",
                        "General Dynamics"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "transportation",
                        "healthcare",
                        "defense"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Watch These Healthcare Stocks in First Week of February",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Stocks",
                        "First Week",
                        "February"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "The 12 Best Dividend Aristocrats - Part 1",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Aristocrats",
                        "Part 1"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividends"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}